FNDC5/irisin-loaded apoptotic nanovesicles encapsulated in photo-crosslinkable PRF-GEL accelerate diabetic wound healing by promoting efferocytosis
Year: 2025
Type: article
Abstract: Background Persistent inflammation in diabetic skin wounds poses significant therapeutic challenges. Fibronectin domain-containing protein 5 (FNDC5), or its cleaved form irisin, is an exercise-induced myokine with anti-inflammatory activity. However, its effect on skin wound repair remains unclear. Methods FNDC5/irisin-overexpressing mesenchymal stem cell-derived apoptotic nanovesicles (apoVIs) were generated. A gelatin methacryloyl (GelMA)/platelet-rich fibrin (PRF) composite hydrogel encapsulating the engineered apoVIs, termed PRF-GEL@apoVIs, was developed for the sustained release of apoVIs. Their effects on macrophage-related inflammation were evaluated in vitro and in vivo. Results Priming bone marrow-derived macrophages with apoVIs promoted macrophage recruitment, efferocytosis, M2 polarization and attenuated inflammatory response resulting from efferocytosis defects. The initial PRF scaffold was effectively stabilized and preserved upon rapid centrifugation of the GelMA precursor solution and whole blood mixture. Following UV crosslinking, the composite hydrogel demonstrated superior stability and sustained-release capabilities of apoVIs. In db/db mice, PRF-GEL@apoVIs significantly accelerated wound closure, enhanced granulation tissue formation, collagen deposition, and angiogenesis, promoted clearance of apoptotic neutrophils, and increased M2 macrophage polarization. Conclusions The PRF-GEL@apoVIs system promotes resolution of inflammation and tissue repair in diabetic wounds by enhancing efferocytosis and modulating macrophage phenotype, representing a promising therapeutic strategy for chronic diabetic wounds.
Source: Materials & Design
Authors: Lihong Qiu, Juanli Dang, Jianxiong Qiao, Xuexin Zhang, Chenggang Yi, Xuanfen Zhang
Language: English
Topic: Wound Healing and Treatments
Subfield: Rehabilitation
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,650
Award: G2625197896
OpenAlex ID: W4414398540
